anmelden
OMX Nordic 40
2.718,06
PKT
+10,11
PKT
+0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.03.24 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 26.03.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 22.03.24 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 18.03.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 18.03.24 | Volvo (B) Buy | Deutsche Bank AG | |
| 15.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.03.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 08.03.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 01.03.24 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 23.02.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 23.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.02.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.02.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 22.02.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 21.02.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.02.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 16.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.02.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 12.02.24 | AstraZeneca Halten | DZ BANK | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 09.02.24 | AstraZeneca Sell | UBS AG | |
| 09.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.02.24 | AstraZeneca Sell | UBS AG | |
| 08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.02.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 06.02.24 | Hennes Mauritz (H M, H&M) Neutral | UBS AG |
